Atecegatran metoxil
Atecegatran metoxil is a oral anticoagulant, which inhibits thrombin factor II and is used in thromboembolic disorders. In vivo, Atecegatran metoxil is converted to AR-H067637, a selective and reversible direct thrombin inhibitor.
Product Specifications
CAS Number
433937-93-0
Product Name Alternative
AZD0837; Atecegatran fexenetil
UNSPSC
12352005
Target
Thrombin
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/atecegatran-metoxil.html
Solubility
10 mM in DMSO
Smiles
O=C([C@H](O)C1=CC(OC(F)F)=CC(Cl)=C1)N(CC2)[C@@H]2C(NCC3=CC=C(C=C3)C(NOC)=N)=O
Molecular Formula
C22H23ClF2N4O5
Molecular Weight
496.89
References & Citations
[1]Lip GY, Rasmussen LH, Olsson SB, et al. Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists. Eur Heart J. 2009;30 (23) :2897-2907. |[2]Olsson SB, Rasmussen LH, Tveit A, et al. Safety and tolerability of an immediate-release formulation of theoral direct thrombin inhibitor AZD0837 in the prevention of stroke and systemic embolism in patients with atrial fibrillation. Thromb Haemost. 2010;103 (3) :604-612.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-N503860-25MG 25 mg
p-Nitrophenyl Beta-D-Lactopyranoside Heptaacetate
Sign In for Pricing
View Details 
LC420659 20 µg
PWWP domain containing protein 2B (PWWP2B) (NM_001098637) Human Over-expression Lysate
Sign In for Pricing
View Details